4.4 Article

Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Forecasting stroke-like episodes and outcomes in mitochondrial disease

Yi Shiau Ng et al.

Summary: This study aimed to determine the characteristics of mitochondrial stroke-like episodes and develop a risk-prediction model. The m.3243A>G variant was found to be the most common genetic cause of stroke-like episodes. The clinical, radiological, EEG, and neuropathological features of stroke-like episodes were consistent with medically refractory epilepsy. Patients with different genetic variants had different disease trajectories and prognoses. The risk-prediction model for the m.3243A>G variant showed good performance. Patients with pathogenic mitochondrial DNA variants were more likely to have radiological and pathological features of neurodegeneration compared to those with POLG-related episodes.

BRAIN (2022)

Review Health Care Sciences & Services

Prevalence of Fatigue in Patients With Cancer: A Systematic Review and Meta-Analysis

Mohammed Al Maqbali et al.

Summary: Fatigue is a common symptom among cancer patients, with an overall prevalence rate of 49% according to this meta-analysis. Female gender is identified as a significant factor associated with higher prevalence of fatigue, while age is not correlated with fatigue.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2021)

Review Clinical Neurology

Mitochondrial disease in adults: recent advances and future promise

Yi Shiau Ng et al.

Summary: In the past five years, significant progress has been made in understanding, diagnosing, and treating mitochondrial diseases. National cohorts and international collaborations have expanded knowledge of the clinical phenotypes and natural history, high-throughput sequencing has altered diagnostic approaches, and efforts are ongoing to find better treatments including drug repurposing and gene therapies. Reproductive technologies also offer opportunities to prevent DNA-related mitochondrial disease transmission.

LANCET NEUROLOGY (2021)

Review Behavioral Sciences

Cognitive functioning and mental health in mitochondrial disease: A systematic scoping review

Inge-Lot Klein et al.

Summary: Patients with mitochondrial diseases may experience cognitive impairments and mental disorders, with high prevalence among both patients and their relatives. Studies showed heterogeneity in patient samples and measurement instruments, but highlighted the importance of further research on natural history.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Review Neurosciences

Anxiety and Brain Mitochondria: A Bidirectional Crosstalk

Michaela D. Filiou et al.

TRENDS IN NEUROSCIENCES (2019)

Article Clinical Neurology

Fatigue in primary genetic mitochondrial disease: No rest for the weary

Sumit Parikh et al.

NEUROMUSCULAR DISORDERS (2019)

Review Rheumatology

Predictors of fatigue in rheumatoid arthritis

Katie L. Druce et al.

RHEUMATOLOGY (2019)

Article Medicine, Research & Experimental

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease

John P. Grady et al.

EMBO MOLECULAR MEDICINE (2018)

Article Psychology, Clinical

Is Fatigue a Disease-Specific or Generic Symptom in Chronic Medical Conditions?

Juliane Menting et al.

HEALTH PSYCHOLOGY (2018)

Article Psychology, Clinical

Fatigue After Breast Cancer Treatment: Biobehavioral Predictors of Fatigue Trajectories

Julienne E. Bower et al.

HEALTH PSYCHOLOGY (2018)

Article Genetics & Heredity

Fear of disease progression in carriers of the m.3243A > G mutation

Jose A. E. Custers et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Article Psychiatry

The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength

M. Worm-Smeitink et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2017)

Article Psychology, Clinical

Heterogeneity in chronic fatigue syndrome - empirically defined subgroups from the PACE trial

T. E. Williams et al.

PSYCHOLOGICAL MEDICINE (2017)

Review Clinical Neurology

Gender differences in Parkinson's disease: A clinical perspective

D. Georgiev et al.

ACTA NEUROLOGICA SCANDINAVICA (2017)

Article Clinical Neurology

Anxiety, depression and fatigue at 5-year review following CNS demyelination

S. Simpson et al.

ACTA NEUROLOGICA SCANDINAVICA (2016)

Article Clinical Neurology

Neuroimaging and clinical predictors of fatigue in Parkinson disease

Kelvin L. Chou et al.

PARKINSONISM & RELATED DISORDERS (2016)

Article Psychology, Clinical

Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model

Melloney L. M. Wijenberg et al.

JOURNAL OF BEHAVIORAL MEDICINE (2016)

Review Endocrinology & Metabolism

MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options

Ayman W. El-Hattab et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Article Clinical Neurology

Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease

Grainne S. Gorman et al.

NEUROMUSCULAR DISORDERS (2015)

Article Clinical Neurology

Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis

B. Wood et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Article Clinical Neurology

Sleep disturbances in chronic progressive external ophthalmoplegia

B. W. Smits et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Article Endocrinology & Metabolism

Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation

Paul de Laat et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2012)

Article Clinical Neurology

Disease impact in chronic progressive external ophthalmoplegia: More than meets the eye

Bart W. Smits et al.

NEUROMUSCULAR DISORDERS (2011)

Review Rheumatology

Biological mechanisms of chronic fatigue

Katrine B. Norheim et al.

RHEUMATOLOGY (2011)

Review Rheumatology

Fatigue Is a Frequent and Clinically Relevant Problem in Ehlers-Danlos Syndrome

Nicol C. Voermans et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)

Article Clinical Neurology

Prevalence of fatigue and depression in ALS patients and change over time

M. C. McElhiney et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Clinical Neurology

Longitudinal correlates of fatigue in multiple sclerosis

E. Patrick et al.

MULTIPLE SCLEROSIS JOURNAL (2009)

Article Clinical Neurology

A longitudinal study of variations in and predictors of fatigue in multiple sclerosis

S. Johansson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Clinical Neurology

Fatigue, depression and progression in multiple sclerosis

M. Koch et al.

MULTIPLE SCLEROSIS JOURNAL (2008)

Article Clinical Neurology

Fatigue in multiple sclerosis persists over time -: A longitudinal study

N. Tellez et al.

JOURNAL OF NEUROLOGY (2006)

Article Clinical Neurology

Mitochondrial disease in adults: A scale to monitor progression and treatment

A. M. Schaefer et al.

NEUROLOGY (2006)

Review Clinical Neurology

Distinguishing sleepiness and fatigue: focus on definition and measurement

JH Shen et al.

SLEEP MEDICINE REVIEWS (2006)

Review Genetics & Heredity

The genetics and pathology of oxidative phosphorylation

J Smeitink et al.

NATURE REVIEWS GENETICS (2001)

Article Health Care Sciences & Services

Adjusting for multiple testing - when and how?

R Bender et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)